JP2008512395A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008512395A5 JP2008512395A5 JP2007530547A JP2007530547A JP2008512395A5 JP 2008512395 A5 JP2008512395 A5 JP 2008512395A5 JP 2007530547 A JP2007530547 A JP 2007530547A JP 2007530547 A JP2007530547 A JP 2007530547A JP 2008512395 A5 JP2008512395 A5 JP 2008512395A5
- Authority
- JP
- Japan
- Prior art keywords
- optionally substituted
- alkyl
- aryl
- hydrogen
- heteroaryl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2004905182A AU2004905182A0 (en) | 2004-09-09 | Enzyme inhibitors and uses thereof | |
| AU2004905182 | 2004-09-09 | ||
| PCT/AU2005/001380 WO2006026832A1 (en) | 2004-09-09 | 2005-09-09 | Enzyme inhibitors and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008512395A JP2008512395A (ja) | 2008-04-24 |
| JP2008512395A5 true JP2008512395A5 (https=) | 2008-10-23 |
| JP5031567B2 JP5031567B2 (ja) | 2012-09-19 |
Family
ID=36036029
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007530547A Expired - Fee Related JP5031567B2 (ja) | 2004-09-09 | 2005-09-09 | 酵素阻害剤およびその使用 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20080194636A1 (https=) |
| EP (1) | EP1789079B1 (https=) |
| JP (1) | JP5031567B2 (https=) |
| KR (1) | KR20070100878A (https=) |
| CN (1) | CN101039690A (https=) |
| CA (1) | CA2579768A1 (https=) |
| DK (1) | DK1789079T3 (https=) |
| ES (1) | ES2403340T3 (https=) |
| IL (1) | IL181819A (https=) |
| NZ (1) | NZ553688A (https=) |
| SG (1) | SG155901A1 (https=) |
| WO (1) | WO2006026832A1 (https=) |
| ZA (1) | ZA200702041B (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009065169A1 (en) | 2007-11-19 | 2009-05-28 | Howard Florey Institute | Insulin-regulated aminopeptidase (irap) inhibitors and uses thereof |
| CN101284820B (zh) * | 2008-04-25 | 2011-05-04 | 南昌大学 | 一种氨肽酶抑制剂及合成方法 |
| CN103848805A (zh) * | 2012-12-06 | 2014-06-11 | 韩冰 | 一类治疗神经退行性疾病的化合物及其用途 |
| CN103896900A (zh) * | 2012-12-25 | 2014-07-02 | 韩冰 | 一类具有神经保护作用的化合物及其制备方法和用途 |
| MX373831B (es) | 2014-05-28 | 2020-03-25 | Astellas Pharma Inc | Derivado de piridina. |
| AR102849A1 (es) | 2015-03-09 | 2017-03-29 | Astellas Pharma Inc | Compuesto de piridina bicíclica |
| CA3017028C (en) | 2015-07-30 | 2020-06-16 | Monash University | Fibrotic treatment |
| EP4440570A1 (en) | 2021-12-01 | 2024-10-09 | Institut National de la Santé et de la Recherche Médicale (INSERM) | Irap inhibitors for use in the treatment of inflammatory diseases |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5284868A (en) * | 1991-10-09 | 1994-02-08 | Eli Lilly And Company | Pharmaceutical compounds |
| US5281619A (en) | 1992-09-25 | 1994-01-25 | Eli Lilly And Company | Therapy for diabetic complications |
| EP1004584A3 (en) | 1992-11-18 | 2000-07-05 | Eli Lilly And Company Limited | Pyranoquinoline derivatives as inhibitors of cell proliferation |
| US6680332B1 (en) * | 1999-06-04 | 2004-01-20 | Euro-Celtique S.A. | Substituted 5-oxo-5,6,7,8-tetrahydro-4H-1-benzopyrans and benzothiopyrans and the use thereof as potentiators of AMPA |
| US7053117B2 (en) * | 2001-05-16 | 2006-05-30 | Cytovia, Inc. | Substituted 4H-chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| WO2003011304A1 (en) * | 2001-08-02 | 2003-02-13 | Howard Florey Institute Of Experimental Physiology And Medicine | Modulation of insulin-regulated aminopeptidase (irap)/angiotensin iv (at4) receptor activity |
| US20030114418A1 (en) * | 2001-08-14 | 2003-06-19 | Pharmacia Corporation | Method for the treatment and prevention of pain and inflammation with glucosamine and a cyclooxygenase-2 selective inhibitor and compositions therefor |
| ES2252656T3 (es) * | 2002-02-13 | 2006-05-16 | F. Hoffmann-La Roche Ag | Nuevos derivados de piridina y quinolina. |
| WO2009065169A1 (en) * | 2007-11-19 | 2009-05-28 | Howard Florey Institute | Insulin-regulated aminopeptidase (irap) inhibitors and uses thereof |
-
2005
- 2005-09-09 NZ NZ553688A patent/NZ553688A/en not_active IP Right Cessation
- 2005-09-09 CN CNA2005800353360A patent/CN101039690A/zh active Pending
- 2005-09-09 DK DK05778990.1T patent/DK1789079T3/da active
- 2005-09-09 EP EP05778990A patent/EP1789079B1/en not_active Expired - Lifetime
- 2005-09-09 CA CA002579768A patent/CA2579768A1/en not_active Abandoned
- 2005-09-09 ZA ZA200702041A patent/ZA200702041B/xx unknown
- 2005-09-09 KR KR1020077008049A patent/KR20070100878A/ko not_active Withdrawn
- 2005-09-09 SG SG200905965-0A patent/SG155901A1/en unknown
- 2005-09-09 ES ES05778990T patent/ES2403340T3/es not_active Expired - Lifetime
- 2005-09-09 JP JP2007530547A patent/JP5031567B2/ja not_active Expired - Fee Related
- 2005-09-09 WO PCT/AU2005/001380 patent/WO2006026832A1/en not_active Ceased
- 2005-09-09 US US11/662,392 patent/US20080194636A1/en not_active Abandoned
-
2007
- 2007-03-08 IL IL181819A patent/IL181819A/en not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10905701B2 (en) | Compositions and methods for inhibiting arginase activity | |
| US10676472B2 (en) | Crystal forms of glutaminase inhibitors | |
| US10793535B2 (en) | Heterocyclic glutaminase inhibitors | |
| ES2243441T3 (es) | Derivados de imidazolio fundidos. | |
| US20160324829A1 (en) | Combination therapy with parp inhibitors | |
| JP2019504113A (ja) | 痛覚過敏を治療する方法 | |
| US20100266674A1 (en) | L-oddc prodrugs for cancer | |
| US20180055843A1 (en) | Combination therapy with glutaminase inhibitors | |
| KR20120055692A (ko) | 화학요법에 의해 유도되는 통증의 예방 또는 치료를 위한 시그마 리간드 | |
| US20160129030A1 (en) | Treatment of mtor hyperactive related diseases and disorders | |
| KR20140043900A (ko) | Ape1 매개된 질환을 치료하기 위한 퀴논 화합물 | |
| US20130225647A1 (en) | Combination therapy with parp inhibitors | |
| TWI736519B (zh) | 治療神經退化性疾病之組合物及方法 | |
| JP2008512395A5 (https=) | ||
| JP2026506429A (ja) | Ｍｔａ協同的ｐｒｍｔ５阻害薬を使用した癌治療 | |
| US9205091B2 (en) | Diazeniumdiolated compounds, pharmaceutical compositions, and method of treating cancer | |
| JP2017515899A (ja) | カンナビノイド受容体メディエータとしてのピラゾール誘導体およびそれらの使用 | |
| AU2020402994A1 (en) | Methods of treating cancer | |
| JP2010511041A5 (https=) | ||
| US12303508B2 (en) | Combinatory treatment strategies of cancer based on RNA polymerase I inhibition | |
| JP5830983B2 (ja) | 抗癌剤の副作用軽減剤 | |
| ES2898072T3 (es) | Métodos para tratar el cáncer de ovario | |
| ES2922752T3 (es) | Composición combinada para prevenir o tratar el cáncer que comprende un derivado de benzofenona-tiazol como VDA y un inhibidor de topoisomerasa | |
| JP2008517065A (ja) | Ｂｒｃａ２−ｒａｄ５１相互作用の破壊のための組成物及び方法 | |
| CA3124820C (en) | Compositions and methods for modulating hair growth |